Amneris Luque is an Infectious Disease physician affiliated with Parkland Memorial Hospital. OpenAlex indexes 69 publications with 1,224 citations (h-index 20); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5323 Harry Hines Blvd
Dallas, TX 753907201
Telephone
214-645-2800Registry record last updated 17 Oct 2016.
Clinical trials
- Atovaquone for Treatment of COVID-19
Sponsor: University of Texas Southwestern Medical Center
- Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
48.9%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor17.1%Tivicay52%Isentress17%Dovato16%Juluca16%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor10.6%Descovy52%Abacavir-Lamivudine48%Part D<11 patients+ 3 more classes in this area
Cardiovascular
28.9%Statin14%Atorvastatin Calcium52%Rosuvastatin Calcium26%Pravastatin Sodium22%Part D<11 patientsACE inhibitor6.5%Lisinopril100%Part D<11 patients+ 2 more classes in this area
Nervous system
16.9%Gabapentinoids10.8%Gabapentin76%Pregabalin24%Part D<11 patientsSSRI6%Fluoxetine Hcl56%Sertraline Hcl44%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Using Machine Learning to Identify Patients at Risk of Acquiring HIV in an Urban Health System
JAIDS Journal of Acquired Immune Deficiency Syndromes
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Nicholas Hendren, MD
Parkland Memorial Hospital
Helen King, MD
Parkland Memorial Hospital
Michelle Machie
Parkland Memorial Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”